Suppr超能文献

具有VP-16(依托泊苷)样活性的4'-去甲基表鬼臼毒素半乳糖吡喃糖苷衍生物的合成及生物活性

Synthesis and biological activity of galactopyranoside derivatives of 4'-demethylepipodophyllotoxin showing VP-16 (etoposide)-like activity.

作者信息

Pamidi C C, Derry W B, Gupta R S

机构信息

Department of Biochemistry, McMaster University, Hamilton, Ontario, Canada.

出版信息

Anticancer Drug Des. 1991 Nov;6(5):481-93.

PMID:1764166
Abstract

To investigate the role of the glucoside moiety in the biological activity of VP-16 (etoposide; 4'-demethylepipodophyllotoxin-ethylidene-beta-D-glucoside) and VM-26 (teniposide; 4'-demethyl-epipodophyllotoxin-thenylidene-beta-D-glucoside), a number of acetal and ketal derivatives of 4'-demethylepipodophyllotoxin (DMEP)-beta-D-galactoside were synthesized. The compounds synthesized included acetaldehyde, propionaldehyde, 2-thiophenecarboxaldehyde, phenylacetaldehyde and acetone derivatives. In contrast to the glucose derivatives, where the acetal ring is trans to the pyranose ring, in galactose derivatives it is located in the cis position. The activities of the above compounds have been measured in two different biological assays, based on cross resistance towards mutants exhibiting specific resistance to VP-16/VM-26-like drugs and DNA-strand breaks as measured by the alkaline elution technique. All of the above compounds showed specific cross resistance to VpmR mutants (mutants resistant to VP-16 and VM-26) and caused a dose-dependent enhancement in DNA-strand breakage, providing evidence that they possessed the same kind of biological activity as VP-16 and VM-26. The relative activities of the DMEP-galactose derivatives have been compared with the corresponding DMEP-glucoside compounds. These studies reveal that, for the acetal and ketal derivatives with small R groups (acetaldehyde and acetone derivatives), the activities in the two series are comparable. However, for derivatives with larger, more hydrophobic R groups (2-thiophene or phenylacetaldehyde), the glucoside derivatives showed about 8-10-fold higher activity in comparison with the corresponding galactoside compounds.

摘要

为了研究葡糖苷部分在VP - 16(依托泊苷;4'-去甲基表鬼臼毒素 - 乙叉基 - β - D - 葡糖苷)和VM - 26(替尼泊苷;4'-去甲基 - 表鬼臼毒素 - 噻吩亚甲基 - β - D - 葡糖苷)生物活性中的作用,合成了多种4'-去甲基表鬼臼毒素(DMEP)-β - D - 半乳糖苷的缩醛和酮缩醛衍生物。合成的化合物包括乙醛、丙醛、2 - 噻吩甲醛、苯乙醛和丙酮衍生物。与葡萄糖衍生物中缩醛环与吡喃糖环呈反式不同,在半乳糖衍生物中它位于顺式位置。上述化合物的活性已在两种不同的生物学测定中进行了测量,一种基于对表现出对VP - 16/VM - 26类药物具有特异性抗性的突变体的交叉抗性,另一种通过碱性洗脱技术测量DNA链断裂。所有上述化合物对VpmR突变体(对VP - 16和VM - 26耐药的突变体)均表现出特异性交叉抗性,并导致DNA链断裂呈剂量依赖性增强,这表明它们具有与VP - 16和VM - 26相同类型的生物活性。已将DMEP - 半乳糖苷衍生物的相对活性与相应的DMEP - 葡糖苷化合物进行了比较。这些研究表明,对于具有小R基团的缩醛和酮缩醛衍生物(乙醛和丙酮衍生物),两个系列中的活性相当。然而,对于具有更大、更疏水R基团的衍生物(2 - 噻吩或苯乙醛),葡糖苷衍生物与相应的半乳糖苷化合物相比,活性高约8 - 10倍。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验